ARS Pharmaceuticals, Inc. — Director's Dealing 2025

Nov 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2025-11-12

Reporting Person: Shah Pratik (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-12	Common Stock	G	250000	—	Disposed	4574554	Indirect
2025-11-12	Common Stock	G	100000	—	Disposed	4474554	Indirect

Footnotes

F1: The transaction involved the gift of shares to a trust in which the Reporting Person is not the trustee and the Reporting Person has no pecuniary interest over shares held in the trust.

F2: The Reporting Person is the trustee of The Pratik Shah Living Trust dated June 15, 2011.

F3: The transaction involved the transfer of shares to a charitable fund.